세계의 인실리코 Drug Discovery 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for In-Silico Drug Discovery Market is presumed to reach the market size of nearly USD 8330.05 Million by 2032 from USD 3099.7 Million in 2023 with a CAGR of 11.61% under the study period 2024-2032.

In-silico drug discovery involves using computer simulations and computational methods to identify and develop new pharmaceuticals. This approach utilizes bioinformatics, molecular modeling, and data analysis to predict how drug candidates interact with biological targets. In-silico techniques can screen vast libraries of compounds, identify potential drug candidates, optimize lead compounds, and predict their pharmacokinetic and toxicological profiles. This method significantly accelerates the drug discovery process, reduces costs, and minimizes the need for extensive laboratory work.

MARKET DYNAMICS

The in-silico drug discovery market is driven by the need for more efficient, cost-effective, and faster drug discovery processes. Advances in computational biology and bioinformatics have significantly enhanced the capabilities of in-silico drug discovery, enabling researchers to predict drug interactions, optimize drug candidates, and identify potential side effects early in development. The rising cost of traditional drug development and the increasing complexity of targeting multifactorial diseases make In-Silico approaches more attractive. Additionally, regulatory support for integrating computational methods in drug development processes encourages more pharmaceutical companies to adopt these technologies. The growing availability of high-performance computing resources and sophisticated software tools further propels the growth of the in-silico drug discovery market. However, computational complexities and data accuracy concerns may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In-Silico Drug Discovery. The growth and trends of In-Silico Drug Discovery industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In-Silico Drug Discovery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Software-as-a-Service
• Software
• Consultancy-as-a-Service

By Workflow

• Pre-Clinical Tests
• Discovery
• Clinical Tests

By Target Therapeutic Area

• Metabolic disorders
• HIV
• Infectious diseases
• Musculoskeletal disorders
• Mental disorders
• Neurological disorders
• Oncological disorders

By End User

• Contract Research Organizations
• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In-Silico Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In-Silico Drug Discovery market include Charles River Laboratories, Curia Global Inc., Certara, USA, Chemical Computing Group ULC, GenScript, Sygnature Discovery, Abzena Ltd., BioNTech SE, Creative Biostructure. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. IN-SILICO DRUG DISCOVERY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Workflow
  • 3.7.3 Market Attractiveness Analysis By Target Therapeutic Area
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Software-as-a-Service Historic and Forecast Sales By Regions
• 5.4. Software Historic and Forecast Sales By Regions
• 5.5. Consultancy-as-a-Service Historic and Forecast Sales By Regions

6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY WORKFLOW

• 6.1. Overview By Workflow
• 6.2. Historical and Forecast Data Analysis By Workflow
• 6.3. Pre-Clinical Tests Historic and Forecast Sales By Regions
• 6.4. Discovery Historic and Forecast Sales By Regions
• 6.5. Clinical Tests Historic and Forecast Sales By Regions

7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY TARGET THERAPEUTIC AREA

• 7.1. Overview By Target Therapeutic Area
• 7.2. Historical and Forecast Data Analysis By Target Therapeutic Area
• 7.3. Metabolic disorders Historic and Forecast Sales By Regions
• 7.4. HIV Historic and Forecast Sales By Regions
• 7.5. Infectious diseases Historic and Forecast Sales By Regions
• 7.6. Musculoskeletal disorders Historic and Forecast Sales By Regions
• 7.7. Mental disorders Historic and Forecast Sales By Regions
• 7.8. Neurological disorders Historic and Forecast Sales By Regions
• 7.9. Oncological disorders Historic and Forecast Sales By Regions

8. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Contract Research Organizations Historic and Forecast Sales By Regions
• 8.4. Pharmaceutical and Biopharmaceutical Companies Historic and Forecast Sales By Regions
• 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN-SILICO DRUG DISCOVERY COMPANIES

• 10.1. In-Silico Drug Discovery Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF IN-SILICO DRUG DISCOVERY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Charles River Laboratories
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Curia Global Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Certara USA
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Creative Biostructure
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Chemical Computing Group ULC
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. GenScript
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Sygnature Discovery
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Abzena Ltd.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. BioNTech SE
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies